Table 3.
Associations of LHX6 Expression with the Clinicopathological Characteristics in Patients with Lung Cancer
| Clinicopathological Feature | No. Cases | LHX6 Expression* | P value** | ||
|---|---|---|---|---|---|
| Positive | Negative | ||||
| Pathological grade | II | 10 | 6 | 4 | 0.299 |
| III above | 5 | 4 | 1 | ||
| Gender | Male | 5 | 1 | 4 | 0.604 |
| Female | 10 | 1 | 9 | ||
| Age (Years) | <54 | 6 | 0 | 6 | 0.231 |
| ≥54 | 9 | 2 | 7 | ||
| Tumor size (cm3) | <28.7 | 8 | 1 | 7 | 0.922 |
| ≥28.7 | 7 | 1 | 6 | ||
Notes: *An immunohistochemical score of 8 is defined as the cut-off value for negative and positive LHX6 expression; **Determined by Kruskal–Wallis test.